Intuitive Surgical (ISRG): Embracing AI Innovations in Robotic Surgery for Future Growth

Sands Capital, an investment management firm, shared its second-quarter 2026 investor letter outlining the performance of the Sands Capital Global Growth Fund. The report found that global equities experienced a rebound in the quarter, primarily driven by advancements in AI infrastructure. This market theme saw strong demand for computing capacity, with large tech firms continuing to invest significantly.

Markets outside the United States, led by Korea and Taiwan, outperformed both U.S. and developed markets for six consecutive quarters.

The global growth fund's portfolio generated a return of 22.2%, surpassing the MSCI All Country World Index's 14.9%. The substantial gains were mainly attributed to earnings growth in AI infrastructure businesses. Investment in information technology and industrials drove the positive results, while financials and communication services contributed to losses.

The letter highlighted Intuitive Surgical, Inc. (NASDAQ:ISRG), a leading provider of robotic surgical systems. As of September 04, 2026, the company's shares closed at $366.70, having experienced a 6.78% decline over the past month and a 21.98% decrease year-to-date. Intuitive Surgical's market capitalization stood at $131.38 billion, with its stock trading within a 52-week range of $328.57 to $603.88.

Despite the broader medtech industry's challenges, the company reported first-quarter 2026 results that exceeded analyst estimates across key metrics. These included revenue, non-GAAP earnings, non-GAAP operating margins, da Vinci procedures, and overall robot placements. Sands Capital expects Intuitive Surgical to introduce several AI features in the coming years, such as anatomy identification, critical structure highlighting during surgery, and eventually, support for surgeon dexterity and automation.

These innovations are anticipated to accelerate robotic surgery adoption and potentially generate software licensing opportunities with higher gross margins than the company's average.

Although Intuitive Surgical isn't currently among the 40 most popular stocks among hedge funds, the fund believes the company's recurring revenue base, market leadership, and long-term AI potential make it an attractive investment. The fund noted that while Intuitive Surgical isn't on their preferred AI stock list, other AI stocks might offer greater upside potential and lower risk.